Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
出版年份 2018 全文链接
标题
Efficacy and Safety of Insulin Glargine 300 U/mL versus 100 U/mL in Diabetes Mellitus: A Comprehensive Review of the Literature
作者
关键词
-
出版物
Journal of Diabetes Research
Volume 2018, Issue -, Pages 1-28
出版商
Hindawi Limited
发表日期
2018-02-13
DOI
10.1155/2018/2052101
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 2 Diabetes
- (2017) Carol Wysham et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes
- (2017) Wendy Lane et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Type 2 diabetes
- (2017) Sudesna Chatterjee et al. LANCET
- Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
- (2017) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Real-world therapeutic benefits of patients on insulin glargine versus NPH insulin
- (2016) Albrecht Fiesselmann et al. ACTA DIABETOLOGICA
- Insulin glargine 300 units/mL: A new basal insulin product for diabetes mellitus
- (2016) J. N. Clements et al. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY
- Clinical Pharmacokinetics and Pharmacodynamics of Insulin Glargine 300 U/mL
- (2016) Jennifer N. Clements et al. CLINICAL PHARMACOKINETICS
- Treatment of Type 2 Diabetes: From “Guidelines” to “Position Statements” and Back
- (2016) Ofri Mosenzon et al. DIABETES CARE
- New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)
- (2016) M. Matsuhisa et al. DIABETES OBESITY & METABOLISM
- New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 2)
- (2016) Y. Terauchi et al. DIABETES OBESITY & METABOLISM
- Sustained glycaemic control and less nocturnal hypoglycaemia with insulin glargine 300U/mL compared with glargine 100U/mL in Japanese adults with type 1 diabetes (EDITION JP 1 randomised 12-month trial including 6-month extension)
- (2016) Munehide Matsuhisa et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Efficacy and Safety of Flexible Versus Fixed Dosing Intervals of Insulin Glargine 300 U/mL in People with Type 2 Diabetes
- (2016) Matthew C. Riddle et al. Diabetes Technology & Therapeutics
- Insulin Glargine 300 U/mL: A Review in Diabetes Mellitus
- (2016) Hannah A. Blair et al. DRUGS
- Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance
- (2016) David R. Owens Expert Opinion on Drug Metabolism & Toxicology
- Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants
- (2016) LANCET
- Concepts and clinical use of ultra-long basal insulin
- (2016) Freddy Goldberg Eliaschewitz et al. Diabetology & Metabolic Syndrome
- Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus
- (2015) Przemyslaw Rys et al. ACTA DIABETOLOGICA
- New Insulin Glargine 300 U/mL for the Treatment of Type 1 and Type 2 Diabetes Mellitus
- (2015) Jennifer Goldman et al. ANNALS OF PHARMACOTHERAPY
- Closed loop insulin delivery in diabetes
- (2015) Tadej Battelino et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 1 Diabetes: A Randomized, Phase 3a, Open-Label Clinical Trial (EDITION 4)
- (2015) Philip D. Home et al. DIABETES CARE
- Patient-level meta-analysis of the EDITION 1, 2 and 3 studies: glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus glargine 100 U/ml in people with type 2 diabetes
- (2015) R. Ritzel et al. DIABETES OBESITY & METABOLISM
- One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension
- (2015) M. C. Riddle et al. DIABETES OBESITY & METABOLISM
- Glycaemic control and hypoglycaemia with new insulin glargine 300 U/ml versus insulin glargine 100 U/ml in people with type 2 diabetes using basal insulin and oral antihyperglycaemic drugs: the EDITION 2 randomized 12-month trial including 6-month extensi
- (2015) H. Yki-Järvinen et al. DIABETES OBESITY & METABOLISM
- New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)
- (2015) G. B. Bolli et al. DIABETES OBESITY & METABOLISM
- Insulin degludec results in lower rates of nocturnal hypoglycaemia and fasting plasma glucose vs. insulin glargine: A meta-analysis of seven clinical trials
- (2015) D. Russell-Jones et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
- (2015) Cristóbal Morales et al. Diabetes Therapy
- Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
- (2015) Cristóbal Morales et al. Diabetes Therapy
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Basal and Mealtime Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 1)
- (2014) Matthew C. Riddle et al. DIABETES CARE
- New Insulin Glargine 300 Units/mL Versus Glargine 100 Units/mL in People With Type 2 Diabetes Using Oral Agents and Basal Insulin: Glucose Control and Hypoglycemia in a 6-Month Randomized Controlled Trial (EDITION 2)
- (2014) Hannele Yki-Järvinen et al. DIABETES CARE
- New Insulin Glargine 300 units{middle dot}mL-1 Provides a More Even Activity Profile and Prolonged Glycemic Control at Steady State Compared With Insulin Glargine 100 units{middle dot}mL-1
- (2014) R. H. A. Becker et al. DIABETES CARE
- U300, a novel long-acting insulin formulation
- (2014) Gemma Sutton et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Higher insulin detemir doses are required for the similar glycemic control: comparison of insulin detemir and glargine in children with type 1 diabetes mellitus
- (2014) Saygın Abalı et al. PEDIATRIC DIABETES
- Safety, effectiveness, and cost effectiveness of long acting versus intermediate acting insulin for patients with type 1 diabetes: systematic review and network meta-analysis
- (2014) A. C. Tricco et al. BMJ-British Medical Journal
- Will the next generation of basal insulins offer clinical advantages?
- (2013) A. J. Garber DIABETES OBESITY & METABOLISM
- Reduced Risk of Hypoglycemia with Insulin Degludec Versus Insulin Glargine in Patients with Type 2 Diabetes Requiring High Doses of Basal Insulin: A Meta-Analysis of 5 Randomized Begin Trials
- (2013) Helena Rodbard et al. Endocrine Practice
- Type 1 diabetes
- (2013) Mark A Atkinson et al. LANCET
- Insulin Detemir
- (2012) Gillian M. Keating DRUGS
- Clinical Experience with Insulin Glargine in Type 1 Diabetes
- (2010) Satish Garg et al. Diabetes Technology & Therapeutics
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- Tolerability, safety and adherence to treatment with insulin detemir injection in the treatment of type 2 diabetes
- (2010) Athena Philis-Tsimikas Patient Preference and Adherence
- Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis
- (2008) M. Monami et al. DIABETES OBESITY & METABOLISM
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started